4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, has today announced an update on its lead Live Biotherapeutic candidate for asthma, MRx-4DP0004. A multicentre ...
Read Article »Market Risers: 4d Pharma PLC, Ferguson, Fresnillo Plc
The trading price for 4d Pharma PLC EPIC code: LON:DDDD has moved up 6.2% or 5.75 points in today’s trading session so far. Buyers have so far held a positive ...
Read Article »Market Risers: 3i Group plc, 4d Pharma PLC, Allergy Therapeutics plc, Anglo American plc
The share price for 3i Group plc with EPIC code: LON:III has increased 1.13% or 12 points during today’s session so far. Investors have remained optimistic while the stock has ...
Read Article »4D pharma plc Presents MRx0518 combination study at ASCO
4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announced the presentation of a poster detailing its Phase I/II clinical study of MRx0518 combined ...
Read Article »4D pharma plc Directors purchase more shares in company
4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, has today announced that David Norwood, Duncan Peyton and Alex Stevenson have purchased ordinary shares in ...
Read Article »4d Pharma PLC 2018 was an exciting year with many goals achieved
4D pharma plc (LON: DDDD), a pharmaceutical company focusing on the development of live biotherapeutics, has today announced the final results for the Group for the year ended 31 December ...
Read Article »Market Risers: Centralnic Group PLC, 4d Pharma PLC, Flowtech Fluidpower PLC & EVRAZ plc
Stock in Centralnic Group PLC with EPIC code: LON:CNIC has increased 11.4% or 6.5 points in today’s trading session so far. Traders are a positive bunch during this period. The ...
Read Article »4D pharma plc Presents Phase Ib Clinical Data on Thetanix®
4D pharma plc (LON: DDDD), a pharmaceutical company focusing on the development of Live Biotherapeutics, has today announced that data from the completed Phase Ib clinical study of Thetanix® for ...
Read Article »4D pharma plc Participation in Neurodegenerative Disease Conferences
4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announced its participation in the Neuro4D conference, Frankfurt, Germany, 13-14 May, 2019. 4D’s Research and ...
Read Article »Market Risers: 4d Pharma PLC, AstraZeneca plc, Croda International & easyJet plc
Shares in 4d Pharma PLC with company EPIC: LON:DDDD has climbed 4.26% or 5.35 points during today’s session so far. Traders are a positive bunch during the session. The period ...
Read Article »